Saranas Receives FDA Approval in March, and already reaches another milestone

Early Bird Bleed Monitoring System developed by Saranas, a GOOSE portfolio company, at the Texas Heart Institute in Houston received a much-anticipated FDA approval in March 2019. Saranas Early Bird Bleed Monitoring System detects bleeding in real-time, allowing doctors to act quickly and improve the outcomes of the procedures and recovery of the patient.  

This month, Saranas reached another milestone as a new study validates the effectiveness of the Saranas Early Bird Bleed Monitoring System. The system successfully detected bleeding events during endovascular related procedures on 60 patients enrolled in the study.

This is very important news for patients who need transcatheter aortic valve replacement, or other large-bore endovascular procedures. Currently, one in five patients experience bleeding complications during these procedures. Saranas Early Bird Monitoring System significantly reduces risk of mortality, length of hospital stays, and healthcare costs caused by bleeding complications. 

Philippe Genereux, MD, principal investigator, cardiologist and physician at Morristown Medical Center in Morristown, NJ commented on the study results: “This is the first time we’re seeing how this device could help in a real-world patient setting, and we were very encouraged by the results. Right now, patients have a risk of vessel injury when undergoing endovascular procedures where the femoral artery or vein is used for vascular access.” GOOSE is extremely excited about the news. We look forward to support Saranas in reaching their next goals.

Open post Medical device startup in Houston

GOOSE Portfolio Company Saranas Heads to Clinical Trials

Saranas Inc, a GOOSE portfolio company and Houston-based medical device startup, recently closed a round of $2.8 million to kick off clinical trails for their Early Bird Bleed Monitoring System. This round brings their total funding to $12 million.

Early Bird Bleed Monitoring System, invented by Dr. Mehdi Razavi at the Texas Heart Institute, is meant to detect bleeding complications during procedures.  The company anticipates FDA approval in early 2019.

In 2017, Saranas was named a finalist for the International Cardiovascular Innovation Award:  one of the most prestigious awards for medical startups worldwide.

startups, ICI, Innovation, GOOSE Society, Houston Funding, Venture
Dr. Phillippe Géneréux (CMO), Kevin Maples (Board Director), and Zaffer Syed (CEO) at the International Conference for Innovations in Isreal.

Larry Lawson, GOOSE board member, and Kevin Maples, a close friend of GOOSE and son-in-law of GOOSE member Dan Steppe, sit on the Board of Directors for Saranas.

A big thank you to Houston Innovation Map and Business Wire for covering Saranas in full detail and the Texas Medical Center Innovation Institute for the support offered to Saranas and countless other healthcare startups.

GOOSE Portfolio Co NuMat Receives $9M contract with US Army

NuMat Technologies received a $9 million contract from the US Army Research, Development, and Engineering Command Chemical and Biological Center (RDECOM C&B).  The contract is to develop and manufacture the next-generation materials that will protect and sustain the warfighter.

NuMat is the first company in the world to commercialize MOF’s (metal organic frameworks), applying them first in the electronics and speciality gas sectors, but with potential applications in life sciences, energy and industrial sectors.  With the new funding, NuMat will build the world’s first dedicated, commercial-scale manufacturing site for MOF’s and a state-of-the-art application development lab for next-generation filtration and purification technologies.

NuMat Technologies a U.S. based tech company innovating at the intersection of high-performance computing, chemistry, and engineered systems.  NuMat’s technology is from Northwestern University and the team won the 2012 Rice Business Plan CompetitionJay Collins, GOOSE President, is on their Board of Directors.

GOOSE Portfolio Company SiNode Enters $4.5M Joint Venture

SiNode Systems, a Chicago-based developer of advanced materials out of Northwestern, and JNC Corporation, a Tokyo-based speciality chemical manufacturer, announced the formation of NanoGraf Corporation, a joint venture focused on commercializing materials for the Lithium-ion battery industry.  NanoGraf Corporation launches with $4.5 million and plans to expand commercial production and continue the development of additional materials platforms.

NanoGraf’s technology enhances the performance of battery materials via a proprietary graphene-wrapped silicon anode and can improve battery energy density by 50%.

Ashok Rao, Board Member of both SiNode and the GOOSE Society, was an integral part of the negotiations.  GOOSE invested in SiNode Systems after the company won the grand prize at the 2013 Rice Business Plan Competition in Houston, TX.

See NanoGraf’s media page for the full press release.

 

 

GOOSE Portfolio Company Fluidity Officially Launches

GOOSE Portfolio Company and Houston based start-up, Fluidity, officially launched last week right in time for the Holiday season!

Fluidity is revolutionizing drone control and their first product is the FT Aviator:  a game-changing drone controller designed by former NASA astronaut, Scott Parazynski and a team of Rice MBA’s. The controller is an intuitive, single-handed design that eliminates the complexity of dual thumb controllers, has advanced camera controls for high-quality photo and video capture, and is compatible with most DJI drones.

Fluidity was also named as a CES 2019 Innovation Awards Honoree.  You can be one of the first to order the FT Aviator on Kickstarter and save $224 off of the expected retail price of $449.

See xconomy’s write up on Fluidity here.

Scroll to top